Skip to main content

and
  1. No Access

    Article

    Traditional risk factors and nodal yield—still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer?

    Patients with locally advanced head and neck cancer (LAHNC) often undergo multimodal therapy including radical resection of the primary tumor and neck dissection (ND) followed by risk-adapted adjuvant radio(ch...

    Y. Butt, P. Tennstedt, C.-J. Busch, H. Hanken, A. Krüll in Strahlentherapie und Onkologie (2023)

  2. No Access

    Article

    Muskuloskelettale Erkrankungen bei Operateuren in der Urologie – besteht ein Zusammenhang mit der offenen Beckenchirurgie?

    Die Auswirkungen der offenen Beckenchirurgie (OBC) auf den Patienten sind Gegenstand vieler Studien. Gesundheitliche Effekte auf den Operateur sind jedoch noch nicht ausreichend betrachtet worden. Die Arbeit u...

    M. Metze, P. Hammerer, G. Horst-Schaper, W.-P. Sollmann, M. Reinshagen in Der Urologe (2020)

  3. Article

    Open Access

    Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer

    Here we report that PTEN contributes to DNA double-strand break (DSB) repair via homologous recombination (HR), as evidenced by (i) inhibition of HR in a reporter plasmid assay, (ii) enhanced sensitivity to mi...

    W. Y. Mansour, P. Tennstedt, J. Volquardsen, C. Oing, M. Kluth in Scientific Reports (2018)

  4. No Access

    Article

    No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer

    To assess the association between blood loss, blood transfusion (BT) and biochemical recurrence (BCR)-free, metastasis-free and overall survival after radical prostatectomy (RP) in a large single-center cohort...

    K. Boehm, B. Beyer, P. Tennstedt, J. Schiffmann, L. Budaeus in World Journal of Urology (2015)

  5. No Access

    Article

    Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results

    HistoScanning™ (HS) is an ultrasound-based tissue characterization technique with encouraging results in the detection of prostate cancer (PCa). The aim of this study was to evaluate the accuracy of total tumo...

    J. Schiffmann, J. Fischer, P. Tennstedt, B. Beyer, K. Böhm in World Journal of Urology (2014)

  6. No Access

    Article

    Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate

    The role of HistoScanning™ (HS) in prostate biopsy is still indeterminate. Existing literature is sparse and controversial. To provide more evidence according to that important clinical topic, we analyzed inst...

    J. Schiffmann, P. Tennstedt, J. Fischer, Zhe Tian, B. Beyer in World Journal of Urology (2014)

  7. No Access

    Article

    Xerostomia after radiotherapy

    Xerostomia is a debilitating side effect of radiotherapy in patients with head and neck cancer. We undertook a prospective study of the effect on xerostomia and outcomes of sparing one or both parotid glands d...

    S. Tribius M.D., J. Sommer, C. Prosch, A. Bajrovic in Strahlentherapie und Onkologie (2013)

  8. No Access

    Article

    Transkriptomweite Expressionsanalysen an pulmonalen Nierenzellkarzinommetastasen

    D. Wuttig, C. Höfling, S. Füssel, M. Meinhardt, A. Herr, P. Tennstedt in Der Urologe (2007)